NCT06933563
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
Clinical trial condition
Myasthenia Gravis
Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.
264 public trials
97 recruiting studies
Myasthenia Gravis trial results
Not yet recruiting
Blinatumomab for Treatment of Refractory Myasthenia Gravis
NCT06836973
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
Not specified
Not yet recruiting
Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis
NCT06827587
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
Not specified
Not yet recruiting
An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06759948
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +11 more
- Locations
-
- Huashan Hospital, affiliated to Fudan University, Shanghai, Shanghai, Shanghai Municipality, China
Not yet recruiting
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
NCT06485232
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +30 more
- Locations
-
- Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China
Not yet recruiting
Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
NCT06723548
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
Not specified
Not yet recruiting
Perioperative Efgartigimod for Thymoma and Myasthenia Gravis
NCT06221501
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
Not specified
Enrolling by invitation
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
NCT07217509
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
- CorEvitas, LLC Waltham, Massachusetts, United States
Enrolling by invitation
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
NCT06540144
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0008 40290 Bologna, Italy
- Mg0008 40144 Milan, Italy
- Mg0008 40733 Naples, Italy
- Mg0008 20340 Fuchu-shi, Japan
Enrolling by invitation
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
NCT06435312
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0015 40144 Milan, Italy
- Mg0015 40774 Katowice, Poland
- Mg0015 40218 Warsaw, Poland
- Mg0015 20220 Seoul, South Korea